New Digital Microscope Boasts Augmented Software
|
By LabMedica International staff writers Posted on 08 Jun 2017 |
|
Image: The Cytation 1 cell imaging multimode reader (Photo courtesy of BioTek Instruments).
A new automated digital quantitative multi-mode microscope has been released for use by biotech and other life science researchers.
The BioTek Instruments (Winooski, VT; USA) Cytation 1 cell imaging multi-mode reader has been cited as an affordable entry into automated digital quantitative microscopy along with multi-mode microplate detection.
This unique, patented design provides quantitative phenotypic cellular information along with well-based quantitative data. Cytation 1's multi-mode detection module includes high sensitivity filter-based fluorescence and a monochromator system for UV-Visible absorbance. Temperature control and shaking are standard; CO2/O2 control and reagent injectors are available as accessories.
The digital microscopy mode includes fluorescence and high contrast brightfield channels for visualization from 1.25 times to 60 times without the expense and complexity commonly associated with other digital microscopy systems. Furthermore, automated XY stage, focus, and LED intensity facilitate imaging throughput, especially during cell-based applications such as three-dimensional spheroid imaging. The multi-mode detection module includes sensitive filter-based fluorescence and luminescence along with monochromator-based UV-Visible absorbance for flexibility in a wide range of endpoint, kinetic, inject/read, and other assay types.
BioTek’s powerful Gen5 software makes image capture and plate reading easy. The latest Gen5 3.03 software offers new functionality for imaging and microplate reading, including spot counting for cellular image analysis and a fluorophore spectra utility for convenience during fluorescence detection protocol definition, and many others.
Cytation 1 can be integrated with BioTek’s BioStack microplate stacker or BioSpa 8 automated incubator to automate throughput and long-term live cell kinetic imaging. The instrument is compatible with a variety of sample vessels, including microplates, slides, cell culture dishes and flasks, hemocytometers, and the Take3 micro-volume plate.
The BioTek Instruments (Winooski, VT; USA) Cytation 1 cell imaging multi-mode reader has been cited as an affordable entry into automated digital quantitative microscopy along with multi-mode microplate detection.
This unique, patented design provides quantitative phenotypic cellular information along with well-based quantitative data. Cytation 1's multi-mode detection module includes high sensitivity filter-based fluorescence and a monochromator system for UV-Visible absorbance. Temperature control and shaking are standard; CO2/O2 control and reagent injectors are available as accessories.
The digital microscopy mode includes fluorescence and high contrast brightfield channels for visualization from 1.25 times to 60 times without the expense and complexity commonly associated with other digital microscopy systems. Furthermore, automated XY stage, focus, and LED intensity facilitate imaging throughput, especially during cell-based applications such as three-dimensional spheroid imaging. The multi-mode detection module includes sensitive filter-based fluorescence and luminescence along with monochromator-based UV-Visible absorbance for flexibility in a wide range of endpoint, kinetic, inject/read, and other assay types.
BioTek’s powerful Gen5 software makes image capture and plate reading easy. The latest Gen5 3.03 software offers new functionality for imaging and microplate reading, including spot counting for cellular image analysis and a fluorophore spectra utility for convenience during fluorescence detection protocol definition, and many others.
Cytation 1 can be integrated with BioTek’s BioStack microplate stacker or BioSpa 8 automated incubator to automate throughput and long-term live cell kinetic imaging. The instrument is compatible with a variety of sample vessels, including microplates, slides, cell culture dishes and flasks, hemocytometers, and the Take3 micro-volume plate.
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Rapid Molecular Testing Device
FlashDetect Flash10
Hemodynamic System Monitor
OptoMonitor
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read more
Molecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read more
Hematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Immunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Microbiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read more
Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Pathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read more
AI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read more
Technology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read more
Industry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more
